Small Hospitals
Market Cap
₹3,271 ₹3,271 Cr.
P/E
17.40
PEG
1.54
PEG = P/E ÷ 5yr forward EPS CAGR
5yr forward EPS CAGR thesis · Base case

Sustained inpatient and outpatient demand, alongside gradual operating-efficiency gains, is the key condition for the thesis to remain on track.

The bull path requires stronger-than-planned near-term revenue and improving consolidated EBITDA margins, while the bear path is triggered by weak growth combined with insurance pricing pressure.

Professional-cost inflation, wage pressure and competition could limit margin conversion even if patient volumes remain resilient.

Key Ratios

Debt to Equity
Debt to Equity
-
Div Yield (%)
Div Yield (%)
1.12
Individual < 2 lac
Individual < 2 lac
22.33 %
Institutions
Institutions
3.35 %
Market cap
Market cap
3,271 Cr
No. of Shareholders
No. of Shareholders
75,098
OPM (%)
OPM (%)
17.96 %
PE
PE
17.40
Prom Holding
Prom Holding
51.00 %
ROCE (%)
ROCE (%)
30.67
ROE (%)
ROE (%)
24.80
Sales
Sales
1,523 Cr
  • Indraprastha Medical
  • Dr Agarwals Eye Hosp
  • KMC Speciality Hosp.
  • TJI Hospitals
Last updated on 6 Aug 2026
  • Indraprastha Medical Corporation runs single-segment healthcare operations on a steadily scaled-up base.
  • Q1FY27 conversion softened as doctor charges outpaced revenue; margin 13.7% versus 14.1%.
  • Debt-free through FY25; ₹32.5Cr work-in-progress under execution, execution not financing the watch.
  • Holding multi-year margin expansion decides near-term earnings.
  • Supreme Court free-treatment case unresolved; contingent claims ₹72–89Cr overhang persists.
  • FY26 dividend and AGM record 18 September 2026; AGM 24 September 2026
    sets payout versus ₹4.50/share prior two years and payment timing.
  • Supreme Court free-treatment PIL No timeline
    decides if obligations shift ₹72–89Cr claims or margins.
  • Capex execution on ₹32.5Cr build No COD stated; nothing through Q1FY27
    fixes COD, capitalised cost and revenue contribution.
Price Range

See where the stock is trading versus its 52-week high and low.

Low
342
52W Range
High
641
Timeline

Key company specific updates.

Custom financial statement

Edit rows

Forensics

10 Yes

Positive for this company

2 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

    Select a Metric
    • Average Daily Revenue Per Occupied Bed (Rs)
    • Hospital Occupancy Rate (%)
    • Average Length Of Stay (Days)
    • Operational Beds (.)

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    FAQs on Indraprastha Medical Corporation Ltd. Business

    Indraprastha Medical Corporation Ltd provides a wide range of medical services and is expanding to set up satellite clinics for post-treatment care.

    Indraprastha Medical major competitors are Dr Agarwals Eye Hosp, KMC Speciality Hosp., Shalby, Artemis MedicareServ, Aashka Hospitals, Fortis MalarHospital, Tejnaksh Healthcare.
    Market Cap of Indraprastha Medical is ₹3,248 Crs.
    While the median market cap of its peers are ₹1,557 Crs.

    Indraprastha Medical seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    Company Filing

    2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release
    Investor Presentation
    Conference Call
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material